UBE3B
Summary: The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin-protein ligases. This gene encodes a member of the E3 ubiquitin-conjugating enzyme family which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme and transfers the ubiquitin to the targeted substrates. A HECT (homology to E6-AP C-terminus) domain in the C-terminus of the longer isoform of this protein is the catalytic site of ubiquitin transfer and forms a complex with E2 conjugases. Shorter isoforms of this protein which lack the C-terminal HECT domain are therefore unlikely to bind E2 enzymes. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2012].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| ubiquitin protein ligase E3B | MIM:608047 | Ensembl:ENSG00000151148 | HGNC:HGNC:13478 | PA134872189 | 12q24.11 |
GO terms in UBE3B
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IBA | GO:0000209 | protein polyubiquitination |
| BP | IEA | GO:0016567 | protein ubiquitination |
| MF | IBA | GO:0061631 | ubiquitin conjugating enzyme activity |
Gene expression in normal tissue: UBE3B
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in UBE3B
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| kegg | hsa04120 | Ubiquitin mediated proteolysis - Homo sapiens (human) |
| reactome | R-HSA-1280218 | Adaptive Immune System |
| reactome | R-HSA-168256 | Immune System |
| reactome | R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation |
| reactome | R-HSA-983169 | Class I MHC mediated antigen processing & presentation |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD351 | GW843682X | 3 |
| iGMDRD152 | 179324-69-7 | 3 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD280 | CYTOCHALASIN B | 3 |
| iGMDRD359 | OSW-1 | 3 |
| iGMDRD126 | Tipifarnib | 2 |
| iGMDRD148 | Pifithrin-mu | 1 |
| iGMDRD1008 | SR-II-138A | 3 |
| iGMDRD116 | CD437 | 3 |
| iGMDRD560 | MK-2206 | 2 |
| iGMDRD546 | BMS-754807 | 3 |
| iGMDRD427 | ABT737 | 3 |
| iGMDRD424 | Tamatinib | 2 |
| iGMDRD523 | Cyanoquinoline, 11 | 3 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD484 | Pluripotin | 2 |
| iGMDRD872 | BRD7137 | 3 |
| iGMDRD399 | Selumetinib | 3 |
| iGMDRD398 | Sepantronium | 2 |
| iGMDRD369 | TGX-115 | 2 |
| iGMDRD524 | ISX-9 | 6 |
| iGMDRD121 | GMX1778 | 1 |
| iGMDRD202 | Curcumin | 1 |
| iGMDRD227 | Fatostatin A | 3 |
| iGMDRD705 | Nakiterpiosin | 2 |
| iGMDRD434 | BMS-536924 | 4 |
| iGMDRD885 | Compound 110 | 6 |
| iGMDRD481 | Dactolisib | 3 |
| iGMDRD318 | PAC-1 | 2 |
| iGMDRD77 | Itraconazole | 2 |
| iGMDRD267 | Oligomycin A | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in UBE3B

